[go: up one dir, main page]

WO2009093007A3 - Immune modulation by regioselectively modified glycosides - Google Patents

Immune modulation by regioselectively modified glycosides Download PDF

Info

Publication number
WO2009093007A3
WO2009093007A3 PCT/GB2009/000131 GB2009000131W WO2009093007A3 WO 2009093007 A3 WO2009093007 A3 WO 2009093007A3 GB 2009000131 W GB2009000131 W GB 2009000131W WO 2009093007 A3 WO2009093007 A3 WO 2009093007A3
Authority
WO
WIPO (PCT)
Prior art keywords
immune modulation
modified glycosides
regioselectively modified
regioselectively
glycosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2009/000131
Other languages
French (fr)
Other versions
WO2009093007A2 (en
Inventor
Eng-Kiat Lim
Paul Kaye
Dianna Joy Bowles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of York
Original Assignee
University of York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of York filed Critical University of York
Publication of WO2009093007A2 publication Critical patent/WO2009093007A2/en
Publication of WO2009093007A3 publication Critical patent/WO2009093007A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

We describe the use of regioselectively glycosylated glycoside scaffolds in the modulation of the immune system.
PCT/GB2009/000131 2008-01-21 2009-01-16 Immune modulation by regioselectively modified glycosides Ceased WO2009093007A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0801032.4 2008-01-21
GBGB0801032.4A GB0801032D0 (en) 2008-01-21 2008-01-21 Immune modulation

Publications (2)

Publication Number Publication Date
WO2009093007A2 WO2009093007A2 (en) 2009-07-30
WO2009093007A3 true WO2009093007A3 (en) 2009-11-26

Family

ID=39166075

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/000131 Ceased WO2009093007A2 (en) 2008-01-21 2009-01-16 Immune modulation by regioselectively modified glycosides

Country Status (2)

Country Link
GB (1) GB0801032D0 (en)
WO (1) WO2009093007A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012086811A1 (en) * 2010-12-22 2012-06-28 味の素株式会社 Food intake suppressant and anti-obesity agent
CN102949404B (en) * 2011-08-16 2016-09-14 中国医学科学院药物研究所 Vanillic acid glucoside derivative purposes in treatment of systemic autoimmune disease
US9375472B2 (en) 2012-03-02 2016-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant
KR101392988B1 (en) 2012-09-13 2014-05-09 건국대학교 산학협력단 Engineered Esherichia coli expressing uridine-diphosphate(UDP)-dependent glycosyltransferase and Synthesis of quercetin 3,7-di-O-rhamnoside from the same
KR102079990B1 (en) 2012-12-27 2020-05-27 킴벌리-클라크 월드와이드, 인크. Water soluble essential oils and their use
MX363275B (en) 2012-12-27 2019-03-15 Kimberly Clark Co Water soluble farnesol analogs and their use.
WO2015114584A1 (en) * 2014-01-31 2015-08-06 Ghimas S.P.A. Polydatin for the treatment of hiv in patients
EP3735233A4 (en) 2018-01-03 2021-10-27 Council of Scientific & Industrial Research GLYCOCONJUGATE COMPOUNDS OF ARTEMISIC ACID, METHOD OF MANUFACTURING AND USING THEREOF
KR20200118158A (en) * 2018-02-06 2020-10-14 상하이 동시 즈회이 바이오로지컬 메디슨 컴퍼니 리미티드 Drugs for Neurodegenerative Diseases and Their Applications
CA3118924A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
KR102187233B1 (en) * 2018-12-07 2020-12-04 경희대학교 산학협력단 Composition for immunity enhancement or anti-inflammatory comprising flavonoid from Brugmansia arborea
CN111658631A (en) * 2020-06-11 2020-09-15 广东盛普生命科技有限公司 Application of gallic acid and its derivatives and structural analogs in preparing anti-coronavirus medicine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032410A2 (en) * 2000-10-19 2002-04-25 Imperial College Innovations Limited Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
WO2007034190A2 (en) * 2005-09-21 2007-03-29 The University Of York Regioselective glycosylation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032410A2 (en) * 2000-10-19 2002-04-25 Imperial College Innovations Limited Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
WO2007034190A2 (en) * 2005-09-21 2007-03-29 The University Of York Regioselective glycosylation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FENG YONG-HONG ET AL: "Low dose of resveratrol enhanced immune response of mice", ACTA PHARMACOLOGICA SINICA, WILEY INTERSCIENCE, vol. 23, no. 10, 1 October 2002 (2002-10-01), pages 893 - 897, XP002378877, ISSN: 1671-4083 *
LAI-YI WANG ET AL: "Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity", JOURNAL OF PHARMACEUTICAL SCIENCE, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 93, no. 10, 23 July 2004 (2004-07-23), pages 2448 - 2457, XP009120641, ISSN: 0022-3549 *
LU WEI ET AL: "Therapeutic dendritic-cell vaccine for simian AIDS", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 9, no. 1, 1 January 2003 (2003-01-01), pages 27 - 32, XP002366697, ISSN: 1078-8956 *

Also Published As

Publication number Publication date
WO2009093007A2 (en) 2009-07-30
GB0801032D0 (en) 2008-02-27

Similar Documents

Publication Publication Date Title
WO2009093007A3 (en) Immune modulation by regioselectively modified glycosides
IL211892A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
EP2282788B8 (en) See-through, reduced-pressure dressings and systems
WO2008073462A8 (en) Computational methods and systems associated with nutraceutical related assays
AP2011005661A0 (en) Unitised building system.
IL211891A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
WO2010118866A8 (en) Trehalulose-containing composition, its preparation and use
WO2011116256A3 (en) Multiphase microarrays and uses thereof
EP2442864A4 (en) Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
WO2012021678A3 (en) Isolated bacteria, methods for use, and methods for isolation
WO2010027590A3 (en) Solution microarrays and uses thereof
WO2011079312A3 (en) Panel system
WO2013028939A3 (en) A modular multi-use thermal imaging system
WO2008002640A3 (en) Methods and systems for analysis of nutraceutical associated components
WO2011006566A3 (en) Monomethoxy-hydroxy-benzylmalonate diesters
AU2008901568A0 (en) Improvements in, or relating to furniture
AU2008100909A4 (en) The Challenge of ............
AU2008901421A0 (en) Hang Glider Lift Augmentation System
AU2008904155A0 (en) Hang Glider Lift Augmentation System
AU2008903539A0 (en) Shelving System
AU2008903010A0 (en) The Levy-traction system
GB0823346D0 (en) System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example Windows
GB0803766D0 (en) System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example windows
GB0811899D0 (en) System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example windows
GB0810373D0 (en) System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example Windows

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09703646

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09703646

Country of ref document: EP

Kind code of ref document: A2